Compile Data Set for Download or QSAR
maximum 50k data
Found 174 with Last Name = 'nagasawa' and Initial = 'k'
TargetAndrogen receptor(Homo sapiens (Human))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50170576(1-(4-{1-[4-(2,3-Dihydroxy-propylamino)-3-methyl-ph...)
Affinity DataKi:  1.17E+3nMAssay Description:Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosteroneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAndrogen receptor(Homo sapiens (Human))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50131270(2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]prop...)
Affinity DataKi:  1.30E+3nMAssay Description:Binding affinity against GST-hARLBD was measured in SC-3 cell by using [3H]-testosterone as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetAndrogen receptor(Homo sapiens (Human))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50170573(3-(4-{1-Ethyl-1-[4-(2-hydroxy-3,3-dimethyl-butoxy)...)
Affinity DataKi:  1.51E+3nMAssay Description:Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosteroneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAndrogen receptor(Homo sapiens (Human))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50170578(1-(4-{1-Ethyl-1-[4-(3-hydroxy-3-methyl-butylamino)...)
Affinity DataKi:  2.90E+3nMAssay Description:Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosteroneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAndrogen receptor(Homo sapiens (Human))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50170582(4-(4-{1-Ethyl-1-[4-(3-hydroxy-3-methyl-butylamino)...)
Affinity DataKi:  3.38E+3nMAssay Description:Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosteroneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVitamin D3 receptor(Gallus gallus)
University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50145539((2S,4R)-2,4-Dihydroxy-6-[2-[(R)-1-((R)-5-hydroxy-1...)
Affinity DataIC50:  0.5nMAssay Description:In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 1(Ovis aries (Sheep))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50088679(2-Phenyl-isoindole-1,3-dione | 2-phenyl-1H-isoindo...)
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA1) against Prostaglandin G/H synthase 1 was calculated relative to aspirinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Ovis aries (Sheep))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50088679(2-Phenyl-isoindole-1,3-dione | 2-phenyl-1H-isoindo...)
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Ovis aries (Sheep))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50066441(2-(2,6-Dimethyl-phenyl)-isoindole-1,3-dione | 2-(2...)
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 1(Ovis aries (Sheep))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50219329(CHEMBL8968)
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA1) against Prostaglandin G/H synthase 1 was calculated relative to aspirinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 1(Ovis aries (Sheep))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50066441(2-(2,6-Dimethyl-phenyl)-isoindole-1,3-dione | 2-(2...)
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA1) against Prostaglandin G/H synthase 1 was calculated relative to aspirinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin G/H synthase 2(Ovis aries (Sheep))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50219329(CHEMBL8968)
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVitamin D3 receptor(Gallus gallus)
University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50145538((S)-1-Benzyl-5-((R)-2-{(R)-4-[2-[(3S,5R)-3,5-dihyd...)
Affinity DataIC50:  1.90nMAssay Description:In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAndrogen receptor(Mus musculus)
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50170576(1-(4-{1-[4-(2,3-Dihydroxy-propylamino)-3-methyl-ph...)
Affinity DataIC50:  7.60nMAssay Description:Androgen antagonistic activity as inhibitory concentration against testosterone-induced SC-3 cell proliferationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAndrogen receptor(Mus musculus)
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50170573(3-(4-{1-Ethyl-1-[4-(2-hydroxy-3,3-dimethyl-butoxy)...)
Affinity DataIC50:  9nMAssay Description:Androgen antagonistic activity as inhibitory concentration against testosterone-induced SC-3 cell proliferationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152041(US8987473, 122)
Affinity DataIC50:  10nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVitamin D3 receptor(Gallus gallus)
University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50145540((S)-5-((R)-2-{(R)-4-[2-[(3S,5R)-3,5-Dihydroxy-2-me...)
Affinity DataIC50:  10nMAssay Description:In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152051(US8987473, 137)
Affinity DataIC50:  10nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin G/H synthase 2(Ovis aries (Sheep))
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50111216(5-Amino-2-((R)-3-methyl-2,6-dioxo-piperidin-3-yl)-...)
Affinity DataIC50: <10nMAssay Description:Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152048(US8987473, 134)
Affinity DataIC50:  13nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152079(US8987473, 183)
Affinity DataIC50:  15nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152017(US8987473, 82)
Affinity DataIC50:  15nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152047(US8987473, 133)
Affinity DataIC50:  16nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152080(US8987473, 185)
Affinity DataIC50:  17nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152026(US8987473, 97)
Affinity DataIC50:  18nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152016(US8987473, 80)
Affinity DataIC50:  18nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAndrogen receptor(Mus musculus)
The University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50329704((R)-3-(4-(3-(4-((R)-2-hydroxy-3,3-dimethylbutoxy)-...)
Affinity DataIC50:  19nMAssay Description:Androgen antagonistic activity as inhibitory concentration against testosterone-induced SC-3 cell proliferationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152011(US8987473, 64)
Affinity DataIC50:  22nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152049(US8987473, 135)
Affinity DataIC50:  23nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152023(US8987473, 89)
Affinity DataIC50:  23nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152015(US8987473, 78)
Affinity DataIC50:  24nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152054(US8987473, 140)
Affinity DataIC50:  24nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152058(US8987473, 145)
Affinity DataIC50:  26nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152020(US8987473, 86)
Affinity DataIC50:  28nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVitamin D3 receptor(Gallus gallus)
University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50404242(CHEMBL2114211)
Affinity DataIC50:  30nMAssay Description:In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152013(US8987473, 68)
Affinity DataIC50:  30nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152042(US8987473, 124)
Affinity DataIC50:  31nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152050(US8987473, 136)
Affinity DataIC50:  34nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152056(US8987473, 143)
Affinity DataIC50:  35nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152040(US8987473, 121)
Affinity DataIC50:  41nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152027(US8987473, 99)
Affinity DataIC50:  41nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152057(US8987473, 144)
Affinity DataIC50:  42nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152024(US8987473, 91)
Affinity DataIC50:  43nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152010(US8987473, 61)
Affinity DataIC50:  46nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152061(US8987473, 148)
Affinity DataIC50:  49nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152055(US8987473, 142)
Affinity DataIC50:  50nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetVitamin D3 receptor(Gallus gallus)
University Of Tokyo

Curated by ChEMBL
LigandPNGBDBM50404243(CHEMBL2114212 | CHEMBL3350688)
Affinity DataIC50:  50nMAssay Description:In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152078(US8987473, 182)
Affinity DataIC50:  52nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152073(US8987473, 171)
Affinity DataIC50:  52nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSolute carrier family 22 member 12(Homo sapiens (Human))
Sato Pharmaceutical

US Patent
LigandPNGBDBM152028(US8987473, 102)
Affinity DataIC50:  52nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The result...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 174 total ) | Next | Last >>
Jump to: